Pharma Distributors Profit from Inflation | Business and Finance News

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded19 Aug 2026

Publisherfeeds.acast.com ↗

Handlerec:20064612

Show notes

Inflation’s rising tide is hitting most businesses hard, but two pharmaceutical distributors are turning the heat into profit. With prices up 3.4% year-over-year — and energy and food costs soaring — companies struggle to pass on costs without losing customers. But McKesson and Cencora? They’re built to thrive. These drug distributors buy at low prices and sell at higher ones under contracts that reward them as drug prices climb. With McKesson raking in over $400 billion in revenue and Cencora moving hundreds of billions annually, their business models are uniquely positioned to profit from “Trumpflation,” offering investors a rare upside in an otherwise tough economy. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0998bd302e68a246

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.